Dendritic Cell Engineering is a methodological framework within immune cell engineering that involves the targeted modification of dendritic cells to enhance their antigen-presenting capabilities, immunomodulatory functions, or therapeutic efficacy in vaccine development and cancer immunotherapy.
447
Publications
28.1K
Citations
2.8K
Authors
753
Institutions
Publications per year
2017–2026
73
Parents
Publications
447
Generation of murine dendritic cells from flt3-ligand–supplemented bone marrow cultures
Kenneth Brasel, Thibaut De Smedt, Jeffery L. Smith et al. · Blood · 2000 · 437 citations
1–5 of 447
Authors
2.8K
- GS
11
h-index
- SS
7
h-index
- AW
7
h-index
- ZB
6
h-index
- JX
6
h-index
1–5 of 2.8K
Institutions
753
University of Pittsburgh
Pittsburgh, United States
18 h-index
104 publications
7.3K citations
Inserm
Paris, France
11 h-index
41 publications
3K citations
Universitätsklinikum Erlangen
Erlangen, Germany
11 h-index
59 publications
6.6K citations
University of Florida
Gainesville, United States
9 h-index
40 publications
2.2K citations
Harvard University
Cambridge, United States
9 h-index
38 publications
3.5K citations
Saskatchewan Cancer Agency
Regina, Canada
8 h-index
37 publications
1.1K citations
UPMC Hillman Cancer Center
Pittsburgh, United States
8 h-index
18 publications
1.5K citations
Friedrich-Alexander-Universität Erlangen-Nürnberg
Erlangen, Germany
8 h-index
40 publications
17.7K citations
1–8 of 753
Venues
- Blood
26 publications · 3.3K citations
23
h-index
- Journal of Immunological Methods
29 publications · 6.1K citations
21
h-index
- Cancer Immunology Immunotherapy
24 publications · 1.3K citations
20
h-index
- Gene Therapy
18 publications · 1.2K citations
17
h-index
- The Journal of Immunology
JI · 16 publications · 1.3K citations
16
h-index
1–5